Comments
The initial public offering of Eris Lifesciences, which closed on Tuesday, was subscribed 3.3 times. While the institutional portion got subscribed 4.68 times, the retail portion got subscribed 3.35 times. However, the non-institutional portion got undersubscribed (0.45 times).
The company’s existing shareholders, ChrysCapital’s investment arm Botticelli’s, founder Amit Bakshi and other investors, including Himanshu Shah and Rakesh Shah, among others, has offered to sell 2.89 crore shares in a price band of ₹600-603.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.